fda drug safety communication naion semaglutide 2025 ๐ Optometrists are warning GLP-1 drugs may pose these types of rare risks ๐ โฌ๏ธ Details in comments Wegovy HD Receives FDA Approval
Description
Who May Be Suitable for Semaglutide or Other GLP-1 Weight-Loss Medicines In Europe, GLP-1-based weight-loss treatments follow strict medical guidelines

GLP-1 options include Wegovy pill or pen, Mounjaro, Ozempic, Zepbound pen or vial
Contact us immediately for any issues or doubts

Weight Management: Empagliflozin may lead to weight loss in some individuals by promoting the excretion of excess glucose and calories through urine

Regular monitoring during treatment can catch changes early, enabling timely interventions
What Happens When You Stop Taking Semaglutide When patients discontinue semaglutide, appetite hormones and hunger signals typically return to baseline levels within weeks